Carboxymefloquine

CAS : 35853-50-0

Ref. 3D-FC19787

Informations sur le produit

• Nom: Carboxymefloquine
• Synonymes: 2,8-Bis(trifluoromethyl)-4-quinolinecarboxylic acidRo 21-5104
• Marque: Biosynth
• Description: Carboxymefloquine is a cytochrome P450 inhibitor that is used as an antiparasitic drug in the treatment of intestinal amebiasis and malaria. Carboxymefloquine inhibits the activity of various cytochrome P450 enzymes, which are involved in the metabolism of other drugs. Carboxymefloquine has been shown to decrease the elimination rate of quinidine and propranolol, which may lead to increased concentrations of these drugs in plasma. Carboxymefloquine also has a long terminal half-life and may cause drug interactions with other drugs that are metabolized by cytochrome P450 enzymes. Clinical studies have shown that carboxymefloquine can be used for the treatment of inflammatory bowel disease (IBD). The clinical relevance of this drug is not fully understood because it does not inhibit prostaglandin synthesis or induce apoptosis in intestinal epithelial cells, unlike other IBD treatments such as

Propriétés chimiques

• Masse moléculaire: 309.17 g/mol
• Formule: C₁₂H₅F₆NO₂
• Degré de pureté: Min. 95 Area-%
• Couleur/Forme: Orange Powder
• InChI: InChI=1S/C12H5F6NO2/c13-11(14,15)7-3-1-2-5-6(10(20)21)4-8(12(16,17)18)19-9(5)7/h1-4H,(H,20,21)
• Code InChI: InChIKey=QJTJIQBSZLFWFS-UHFFFAOYSA-N
• SMILES: O=C(O)c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12